Empire State Realty Trust Welcomes Zentalis Pharmaceuticals to 1359 Broadway NEW YORK , April 20, 2021 |PRNewswire| -- Empire State Realty Trust, Inc. (NYSE: ESRT ) announced today that Zentalis Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics that target fundamental biological pathways of cancers, has signed a new lease with ESRT for a 31,362 square foot office space at 1359 Broadway. "At Zentalis, we are committed to ensuring our employees' safety and wellbeing, and we are thrilled our new corporate office space will provide our growing team with a healthy and productive work environment to help bring innovative cancer treatments to patients," commented Dr. Anthony Sun , chairman and chief executive officer of Zentalis Pharmaceuticals. "As we continue to expand our Company's presence in New York City , minimizing the environmental impacts of our business remains a key priority. We look forward to moving into one of ESRT's buildings later this year, as the space is dedicated to instilling energy efficiency and sustainable practices." With a view of the Broadway pedestrian mall and Herald Square, 1359 Broadway contains 22 stories and 455,849 rentable square feet …